Wound Management News

Implicit racial bias could play a part in antibiotics prescribed for skin and soft tissue infections, according to a research letter published in JAMA Network Open.

Acute generalized exanthematous pustulosis is usually triggered by new antimicrobials and is often improved with the discontinuation of the causing drug, according to a study.

Patients who underwent complex reconstruction following Mohs micrographic surgery were more satisfied with their appearance and scars in the long-term, according to a presentation.

Multiple debridements and the use of flaps are associated with longer closure times on complex infectious wounds, according to a study presented at the American Society for Dermatologic Surgery virtual meeting.

Vyjuvek was effective in healing the majority of dystrophic epidermolysis bullosa wounds in a phase 3 trial, Krystal Biotech announced in a press release.

A prediction model presented at ACR Convergence 2021 demonstrated that the use of platelet inhibitors could predict a lower probability of digital ulcer occurrence among patients with systemic sclerosis.

Individuals with recessive dystrophic epidermolysis bullosa who have larger wound sizes are more likely to have worsening skin disease severity and quality of life, according to a study.

Scars — whether from burns, injuries or other causes — can impact an individual’s life in many ways, and oftentimes these physical marks first appear in childhood.

So-called “COVID toes” and other cutaneous manifestations of the virus are not the only dermatologic challenges that a rheumatologist may face, according to a presenter at the 2021 Congress of Clinical Rheumatology-East.

A phase 3 trial showed the majority of burns treated with StrataGraft did not require autografting and achieved durable wound closure, Mallinckrodt announced in a press release.